A Stanford University study presented at the American College of Cardiology’s annual session finds no significant differences ...

In sharp contrast to earlier studies, patients with severe triple-vessel heart disease fared equally well whether they underwent open-heart bypass surgery (CABG) or a less invasive procedure called ...

Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention ...

Findings from the American College of Cardiology 2025 Annual Scientific Session show oral semaglutide reduces the risk of heart attack, stroke, and cardiovascular death by 14% in patients with type 2 ...

The Eli Lilly drug caused a major drop in the blood levels of Lp(a), but further research is needed to show that it will ...

The rate of cardiovascular death, nonfatal heart attack, or nonfatal stroke was 30% lower among patients receiving nurse-led ...

In the RIVAWAR trial, patients hospitalized for a heart attack who were treated with rivaroxaban for left ventricular ...

The results pave the way for Rybelsus to become a new treatment option for people living with diabetes and established heart ...

A new study found that people under the age of 50 who use marijuana are six times more likely to have a heart attack and four ...

A large clinical trial, co-led by researchers at the UNC School of Medicine, has shown that the popular weight-loss drug ...

New research links regular cannabis use with heart attack and other adverse cardiovascular events in otherwise healthy adults ...

Charles T Folsom Jr blends nursing expertise and technology to tackle heart health challenges in African American communities ...